You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study

 

Online download statistics by month:

Online download statistics by month: July 2020 to March 2024

AbstractFullPdf
Jul 202018718744
Aug 202017317470
Sep 2020878745
Oct 2020868630
Nov 2020717125
Dec 2020787828
Jan 2021767619
Feb 2021888824
Mar 202113213243
Apr 2021616139
May 202114714724
Jun 2021828229
Jul 2021767641
Aug 2021515230
Sep 2021717151
Oct 2021828250
Nov 2021636242
Dec 2021626224
Jan 2022757743
Feb 2022586230
Mar 2022646569
Apr 2022909441
May 20229711760
Jun 202214416156
Jul 2022909126
Aug 2022717318
Sep 2022586635
Oct 2022808435
Nov 2022666620
Dec 2022545422
Jan 2023787917
Feb 2023909131
Mar 2023596015
Apr 2023535316
May 2023676823
Jun 2023717539
Jul 2023383827
Aug 2023474710
Sep 2023343515
Oct 2023626222
Nov 2023696915
Dec 2023848422
Jan 2024596018
Feb 2024535327
Mar 202411511687
Total359936741497